Xcout IntelYarrow Bioscience competitors & alternatives
The 12 closest competitors and alternatives to Yarrow Bioscience among pharmaceutical companies — ranked by similarity to what Yarrow Bioscience actually does, not by market-cap band.
Subscribe to see Yarrow Bioscience’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Yarrow Bioscience
Yarrow Bioscience is a U.S.-based biotechnology company focused on the development of treatments for autoimmune diseases. The company has been involved in significant pharmaceutical deals, including the acquisition of drug candidates for thyroid conditions.
Yarrow Bioscience at a glance
Yarrow Bioscience is a pharmaceutical company headquartered in New Haven, United States. It is publicly listed (YARW) with a market capitalisation of $602,204. Xcout tracks 24 named people at Yarrow Bioscience, including David T. Domzalski (Chief Executive Officer, President & Director).
Yarrow Bioscience leadership
- David T. DomzalskiChief Executive Officer, President & Director
- Rebecca Velez FreyChief Executive Officer, President & Director
- Rachael Alford, PhDChief Operating Officer
- Tyler ZerondaChief Financial Officer
- Iain A. StuartChief Scientific Officer
- Mutya HarschGeneral Counsel, Chief Legal Officer & Company Secretary
18 more named people on record for Yarrow Bioscience, with roles, board committees and tenure — see the full roster →
Recent Yarrow Bioscience news
2 corporate events on record, with sources — see the full timeline →
Top 12 Yarrow Bioscience competitors
Ranked by semantic similarity — how close each company is to Yarrow Bioscience by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Pharmaceuticals
Harrow is a Nashville, Tennessee-based pharmaceutical provider that entered into an agreement to acquire the Tyrvaya dry eye treatment from Viatris Inc.
Pharmaceuticals
Sparrow Pharmaceuticals, Inc. is a Boston-based biopharmaceutical company focused on developing targeted cardiometabolic therapeutics. The company aims to address conditions such as diabetes and endocrine diseases with precision therapies.
Pharma
Bionyra Pharma is a clinical-stage biopharmaceutical company focused on developing next-generation biologics for severe immunological and inflammatory conditions. The company launched with a $165 million oversubscribed Series A funding round.
Pharmaceuticals
Highlightll Pharma is a clinical-stage biopharmaceutical company headquartered in Hangzhou, China. The firm focuses on the research and development of treatments for both peripheral and central autoimmune and inflammatory diseases.
Biotechnology & Pharmaceuticals
CymaBay Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in Newark, California, focused on developing therapies for liver and other chronic diseases before being acquired by Gilead Sciences.
Biotechnology & Pharmaceuticals
NYB Holdings Ltd operates an AI-first drug discovery and biotechnology platform that utilizes a large natural compound library and predictive modeling to identify bioactive compounds. The company develops science-backed wellness solutions for nutraceutical applications and advances high-potential drug candidates into preclinical development for the pharmaceutical industry.
Pharmaceuticals
Harrow Health, Inc. is a specialty pharmaceutical company focused on ophthalmic products, including FDA-approved and compounded medications used in eye care. It serves ophthalmologists, other eye-care professionals, and patients requiring treatments for conditions and procedures involving the eye.
Pharmaceuticals
InnoCare Pharma is a China-focused biopharmaceutical company that discovers and develops innovative medicines, particularly for oncology and autoimmune diseases. It serves patients and healthcare providers through research, clinical development, and commercialization of targeted therapies.
Pharmaceuticals
Vyome Holdings, Inc. operates as a healthcare firm currently in its clinical development phase, concentrating on the creation of innovative medicinal treatments designed to address both immuno-inflammatory conditions and infrequent disorders. Founded in 2017, the company extends its market reach throughout the United States and into global territories, headquartered in Princeton, New Jersey.
Pharmaceuticals
Boston Pharmaceuticals is a U.S.-based clinical-stage biopharmaceutical company that acquires, develops, and advances drug candidates for serious diseases. It works with pharmaceutical and biotechnology partners to bring clinical-stage medicines toward commercialization and serves patients with significant unmet medical needs.
Pharmaceuticals
J-Pharma Co., Ltd. is engaged in drug discovery and development, focusing on amino acid transporters as drug targets. The company researches and develops drugs targeting solute carrier (SLC) transporters, with emphasis on the LAT1 amino acid transporter. It is developing several compounds for various medical indications, including JPH034 for central nervous system demyelinating diseases and multiple sclerosis. The company conducts functional and structural analysis of selected SLC transporters to support drug discovery, collaborates with academic institutions, and participates in joint research for new pharmaceutical development. It is preparing for clinical trials and global distribution of its drug candidates. The company was founded in 2005 and is based in Yokohama, Japan.
Pharmaceuticals
Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. In 2018, they opened a subsidiary in the US. Zealand Pharma forms part of the Danish-Swedish life science cluster Medicon Valley.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Yarrow Bioscience and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Yarrow Bioscienceand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →